Legislation governing equine medication policy is scheduled to be heard Feb. 18 by the Florida Senate Regulated Industries Committee.
A fourth Maryland trainer has been suspended and fined in connection with a positive test for the synthetic anabolic steroid stanzolol.
Though the Association of Racing Commissioners International remains a member of the Racing Medication and Testing Consortium, it intends to take the lead role in gathering the information needed to set medication policies.
The umbrella group for regulators in North America is examining a new approach to out-of-competition testing that would not only target blood doping and gene doping, but also identify horses at risk of catastrophic injury.
The Stronach Group remains optimistic about the future of the horse racing industry in North America and will continue to push for what it believes are fundamental structural changes needed to move the business forward.
The racing and breeding industry in North America is devising a plan of action to accommodate the British Horseracing Authority's zero-tolerance policy for the presence of anabolic steroids in Thoroughbreds.
As part of an examination of its equine medication rules, the Ohio State Racing Commission in February will begin hearing from various industry organizations involved in an effort to adopt uniform policies for all states.
The National Horsemen's Benevolent and Protective Association will address a number of issues during its winter convention Feb. 4-8 in Carefree, Ariz., as well as hear from a key executive with The Stronach Group.
The Organization of Racing Investigators will hold its 2015 training conference March 1-4 at New Meadowlands in East Rutherford, N.J.
As part of its extensive investigation into Steve Asmussen stable following allegations of horse mistreatment from an animal rights group, the KHRC compiled safety numbers in which the trainer fared well
The Indiana Horse Racing Commission Jan. 12 said regulation of cobalt, a naturally occurring substance in racehorses that can have performance-enhancing qualities when supplemented, indicates decreases in abuse.
Three regulatory veterinarians said Jan. 12 they support recent action by the Association of Racing Commissioners International to adopt a model rule on compounded drugs used in horse racing.
Citing unresolved investigations in New York and Kentucky of Steve Asmussen following a 2014 video from an animal rights group alleging horse abuse, the trainer will not be considered in 2015 for the Hall of Fame.
RCI said Jan. 5 it is taking steps to ensure regulatory agencies have adequate authority to sanction licensees who violate existing federal restrictions limiting the use of illegally compounded medications.
Trainer David Wells pleaded guilty in a state court Dec. 16 to rigging races by administering drugs to horses on race day at Penn National Race Course.
The RMTC said Dec. 9 the Thoroughbred industry has made "major gains" this year in the number of jurisdictions operating or soon to be operating under all or part of the National Uniform Medication Program.
New York regulators are ready to consider final revisions to rules specifying allowable testing threshold levels for two dozen medications used to treat Thoroughbreds in advance of races.
Maggi Moss has had success racing at Indiana Grand Race Course, which she calls a bright spot in Midwest Thoroughbred racing. But dysfunction and unfair practices in racing regulation are threatening the business, she said.
All samples collected from horses that competed in the 2014 Breeders' Cup at Santa Anita Park have been cleared by the Kenneth L. Maddy Equine Analytical Chemistry Laboratory at UC-Davis.
As Santa Anita Park prepares to host the Breeders' Cup World Championships Oct. 31-Nov. 1, track management is confident its new dirt surface will perform well and safely.
The Breeders' Cup World Championships will be held for the first time under reforms included in the National Uniform Medication Program.
The recent announcement by Breeders' Cup to ban horses from being entered in the World Championships if their trainers are found to be in violation of its convicted trainers rule, effective 2015, could signal change.
- By Tom LaMarra
Research commissioned by The Jockey Club shows that, though the Thoroughbred industry has made progress in the area of uniform medication and testing standards, a state-by-state approach is at best problematic.
Ogden Phipps said Oct. 6 a centralized regulatory body for horse racing would facilitate changes necessary to improve the integrity of the sport in the United States, but the chances of it happening are slim to none.
- By Tom LaMarra
United States Trotting Association-funded research into cobalt has resulted in a regulatory testing threshold of 70 parts per billion, the organization said Sept. 30.
Two of three distinguished veterinarians being honored by the Thoroughbred Club of American, Dr. Larry Bramlage and Dr. Gary Lavin, addressed medication use in racehorses during their acceptance speeches.
Jockey Club says a recent study's findings challenge long-held opinions in North American racing, including the contention that the use of the diuretic furosemide is necessary to ensure long-term careers of horses.
Unless horse racing first reaches industry consensus on medication reform, the National Thoroughbred Racing Association does not expect Congress to move forward on federal medication legislation.
A Kentucky racing official Sept. 12 said the state has been at the forefront of research into cobalt, a naturally occurring element said to have blood-doping qualities if used at high levels.
The Arkansas Racing Commission approved the entire program Sept. 11. Once implemented, Arkansas will become the sixth state to fully administer the Racing Medication and Testing Consortium's National Uniform Medication rules.
The Indiana Horse Racing Commission Sept. 4 voted 3-0 to approve rules to regulate cobalt levels in Thoroughbred and Standardbred racehorses.
The New York State Gaming Commission Sept. 4 said it will issue a standard 10-year suspension to anyone who violates the harness racing rule prohibiting the use of substances that abnormally oxygenate a horse's blood.
Denver Broncos receiver Wes Welker, who made a splash at this year's Kentucky Derby Presented by Yum! Brands (gr. I), was suspended for four games by for violating the NFL's performance-enhancing drug policy.
An analysis of more than 350 blood samples has led the Indiana Horse Racing Commission to recommend establishing a testing threshold level for cobalt and classifying the substance as Class A.
A backlog at its primary laboratory has led the Indiana Horse Racing Commission to contract with second lab on an emergency basis.
Gulfstream Park, which plans to become the racetrack prototype for integrity in the sport, is to to offer furosemide-free races for 2-year-olds in 2015 and eventually operate an on-track pharmacy to control medication.
Continued improvement in regard to equine health and welfare is closely tied to major cultural changes in horse racing, panelists suggested Aug. 12 at the Saratoga Institute on Racing & Gaming Law in Saratoga Springs, N.Y.
The head of the United States Anti-Doping Agency Aug. 11 outlined how the organization could assist the Thoroughbred racing industry should its factions come together and push for federal legislation.
The Jockey Club Aug. 10 acknowledged progress on the effort to adopt uniform medication and drug-testing rules on a state-by-state basis, but also said it will advocate on the federal level for assistance.
In response to a statement from 25 prominent horsemen calling for a ban on the race-day use of furosemide, the Florida Horsemen's Benevolent and Protective Association Aug. 8 issued an open letter opposing changes.
The Association of Racing Commissioners International has released a state-by-state breakdown of the results of equine drug testing in 2013.
The West Virginia Racing Commission Aug. 1 hired Truesdail Laboratories in California to handle its equine drug testing and will ask the lab to test about 40 "cloudy samples" from a three-week period in July.
The Association of Racing Commissioners International is considering rules to govern racehorses in training in an attempt to identify whether they are at risk for injury.
The Delaware Thoroughbred Horsemen's Association and Delaware Park are working to ensure horsemen are promptly paid purse money in light of delays in the receipt of results of equine drug tests.
The Delaware Thoroughbred Racing Commission is working with LGS laboratory in Lexington, Ky., to facilitate quicker turnaround for equine drug test results.
Multiple racing jurisdictions have adopted all or parts of the National Uniform Medication Program, with others expected to be on board by the end of this year.
As the North American Thoroughbred industry continues its quest to lower the catastrophic breakdown rate, it is actively pushing the need to identify at-risk racehorses, even if the effort makes stakeholders uncomfortable.
The National Uniform Medication Program wasn't on the agenda at the recent American Horse Council convention, but progress on that front was addressed during forums and in conversations among attendees.
The Jockey Club should push for more in-depth furosemide research. read blog
The United States Trotting Association said June 16 it will fund a project designed to develop regulatory controls for the use of cobalt in racehorses.
Most Popular Stories
- Nyquist Draws Post 13, is 3-1 Derby Favorite
- Field of 22 Set for 142nd Kentucky Derby
- Fresh Horses Plentiful in 2016 Kentucky Derby
- Ramseys Go It Alone with Oscar Nominated
- Full Gate for Pat Day Mile
- Trainer Abrams Takes Leave of Absence
- Rachel's Valentina 7-2 Oaks Favorite
- Gryder Seeks First Derby With Trojan Nation
- Nyquist Jogs, Schools at Churchill Downs
- Owner Bryan Shares Credit for Exaggerator